DE1961527A1 - Kristalline Form von Citronensaeureanhydrid - Google Patents
Kristalline Form von CitronensaeureanhydridInfo
- Publication number
- DE1961527A1 DE1961527A1 DE19691961527 DE1961527A DE1961527A1 DE 1961527 A1 DE1961527 A1 DE 1961527A1 DE 19691961527 DE19691961527 DE 19691961527 DE 1961527 A DE1961527 A DE 1961527A DE 1961527 A1 DE1961527 A1 DE 1961527A1
- Authority
- DE
- Germany
- Prior art keywords
- anhydride
- citric
- citric acid
- reaction
- crystalline form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 title description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 229960000583 acetic acid Drugs 0.000 claims description 6
- 239000012362 glacial acetic acid Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 description 11
- 150000008064 anhydrides Chemical class 0.000 description 8
- 229960004106 citric acid Drugs 0.000 description 5
- 239000007787 solid Substances 0.000 description 4
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 description 3
- 229960004543 anhydrous citric acid Drugs 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- -1 alkali metal bicarbonate Chemical class 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- VXRUADVCBZMFSV-UHFFFAOYSA-N 2-acetyloxypropane-1,2,3-tricarboxylic acid Chemical compound CC(=O)OC(CC(O)=O)(CC(O)=O)C(O)=O VXRUADVCBZMFSV-UHFFFAOYSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78343168A | 1968-12-12 | 1968-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1961527A1 true DE1961527A1 (de) | 1970-06-25 |
Family
ID=25129225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19691961527 Pending DE1961527A1 (de) | 1968-12-12 | 1969-12-08 | Kristalline Form von Citronensaeureanhydrid |
Country Status (4)
Country | Link |
---|---|
DE (1) | DE1961527A1 (enrdf_load_stackoverflow) |
ES (1) | ES374394A1 (enrdf_load_stackoverflow) |
FR (1) | FR2025932A1 (enrdf_load_stackoverflow) |
GB (1) | GB1229527A (enrdf_load_stackoverflow) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1939219A1 (en) * | 2006-12-29 | 2008-07-02 | Sigea S.R.L. | Polysaccharides derivatised with citric acid |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4429691A1 (de) * | 1994-08-22 | 1996-02-29 | Basf Ag | Verfahren zur Herstellung von Polykondensaten der Citronensäure und ihre Verwendung in Wasch- und Reinigungsmitteln |
-
1969
- 1969-11-17 GB GB1229527D patent/GB1229527A/en not_active Expired
- 1969-11-21 FR FR6940064A patent/FR2025932A1/fr not_active Withdrawn
- 1969-12-08 DE DE19691961527 patent/DE1961527A1/de active Pending
- 1969-12-10 ES ES69374394A patent/ES374394A1/es not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1939219A1 (en) * | 2006-12-29 | 2008-07-02 | Sigea S.R.L. | Polysaccharides derivatised with citric acid |
Also Published As
Publication number | Publication date |
---|---|
GB1229527A (enrdf_load_stackoverflow) | 1971-04-21 |
FR2025932A1 (enrdf_load_stackoverflow) | 1970-09-11 |
ES374394A1 (es) | 1972-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1445154C3 (de) | 1,4-Dihydro-1,8-naphthyridinderi vate und ein Verfahren zu ihrer Herstellung | |
DE2228012C3 (de) | Phthalidester der 6- [D(-)- a Aminophenylacetamido] -penicillansäure und Verfahren zu seiner Herstellung | |
DE3215610C2 (de) | N-Acylthiazolidine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE1961527A1 (de) | Kristalline Form von Citronensaeureanhydrid | |
DE2005959A1 (de) | 7-Nitro-8-hydroxychinolinester, ihre Verwendung und Verfahren zur Herstellung derselben | |
EP0033066A2 (de) | Penicillinderivate, Zwischenprodukte für ihre Herstellung, pharmazeutische Präparate enthaltend dieselben, ihre Herstellung, sowie ihre Verwendung | |
DE1493797A1 (de) | Verfahren zur Herstellung von neuen substituierten Malonsaeuremonohydraziden | |
DE3887612T2 (de) | Salicylate, ihre Salze, diese enthaltende pharmazeutische Kompositionen und ihr Herstellungsverfahren. | |
DE2244179C3 (de) | D-threo-l-p-substituierte Phenyl-2dichloracetamidopropan-I.S-diol-ester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE1493513C3 (de) | Sulfamylanthranilsäuren, deren therapeutisch verwendbare Salze, Verfahren zu ihrer Herstellung und diese enthaltenden pharmazeutischen Präparate | |
DE928286C (de) | Verfahren zur Herstellung eines neuen, analgetisch wirksamen 1-Phenyl-pyrazolderivates | |
DE2050072C3 (de) | Aluminium-tri-3-acetyl-18 betaglycyrrthetinat, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen | |
DE2241076B2 (de) | Tetracyclinkomplex und dessen Salze, Verfahren zu dessen Herstellung und diesen Komplex enthaltende pharmazeutische Zusammensetzungen | |
DE673485C (de) | Verfahren zur Darstellung von 1-Ascorbinsaeure | |
DE1224738B (de) | Verfahren zur Herstellung von Cholestan-3, 5, 6-triol-3-estern oder -3, 6-diestern soowie von deren Salzen | |
DE957123C (de) | Verfahren zur Herstellung von Thioabkoemmlingen der Colchiceine | |
DE963514C (de) | Verfahren zur Herstellung schwerloeslicher kristallisierter Streptomycin- und Dihydrostreptomycinsalze | |
DE1593807C (de) | alpha Äscinmethyl- bzw. -äthy(ester, sowie ein Verfahren zu deren Herstellung | |
AT221501B (de) | Verfahren zur Herstellung der neuen 4-Chlor-3-sulfamyl-benzoesäure und deren Alkalisalze | |
DE578941C (de) | Verfahren zur Darstellung von Santoninderivaten | |
DE2238260C3 (de) | Phosphorsäuremonoester von 5-(2-Dimethylaminoäthoxy)-carvacrol, Verfahren zu seiner Herstellung und diesen enthaltende Arzneimittel | |
AT249031B (de) | Verfahren zur Herstellung von neuen Derivaten des Chloramphenicols | |
DE3215482C2 (de) | Komplexe aus Natriumsalzen von 4-Hydroxy-cumarinen und Alkoholen und Verfahren zu deren Herstellung | |
DE1418518C (de) | Salze der Hydrochinonsulfonsaure und Verfahren zu ihrer Herstellung | |
AT339911B (de) | Verfahren zur herstellung eines neuen 1-phthalazonderivates |